Isosceles Pharmaceuticals, Inc., a preclinical stage pharmaceutical company ("Isosceles", or the "Company") engaged in the development of synthetic cannabidiol for the treatment of pain has announced the execution of a non-binding letter of intent with a strategic partner for the phase 1 development of the Company's intravenous product, IPI 201. The non-binding letter of intent […]
Growing Isosceles Pharmaceuticals team pushes to develop novel, non-opioid products to treat acute pain Isosceles Pharmaceuticals welcomed two new team members – Herbert Neuman, MD, MBA, and Thomas L. Harrison LH.D – to their award-winning mission. The early-stage venture launched two years ago, setting out to formulate and commercialize products that effectively and safely treat […]
Seasoned pharmaceutical executive with more than 30 years of Commercial and Business Strategy experience Isosceles Pharmaceuticals Inc. a biotechnology company dedicated to developing, commercializing, and marketing innovative non-opioid products for the treatment of mild to moderate pain and inflammatory diseases, today announced the appointment of William D. Humphries as its Chief Executive Officer. Mr. Humphries […]
SOURCE: GREATER WILMINGTON BUSINESS JOURNAL BY JENNY CALLISON BIOTECH | ISOSCELES PHARMACEUTICALS INC. BRETT LANIER, PRESIDENT | YEAR FOUNDED: 2019 | EMPLOYEES: 7 (Photo by Terah Wilson) Early-stage venture Isosceles Pharmaceuticals is working on developing non-opioid pain relief alternatives to opium-derived drugs such as Oxycodone. Working with a group of medical doctors and pharmaceutical Ph.D.s, […]
Isosceles Pharmaceuticals recently won a 2020 Coastal Entrepreneur Award (CEA) for the Biotechnology category. The industry accolades – presented by the Greater Wilmington Business Journal and The Center for Innovation and Entrepreneurship (CIE) at the University of North Carolina Wilmington – celebrate rising ventures in the Cape Fear region. “Our entire team is honored to […]
Isosceles Pharmaceuticals was named the first-place winner of the NC BIONEER Venture Challenge which aims to enhance life sciences and biotechnology business ventures in the region. Article from WilmingtonBiz.com. A Wilmington company developing non-opioid solutions for pain relief is the first-place winner of the inaugural NC BIONEER Venture Challenge, according to an announcement Tuesday. Isosceles […]
